DEGRO statement on the KEYNOTE-689 trial: Perioperative immunotherapy in combination with adjuvant (chemo-)radiotherapy for resectable locally advanced head and neck cancers

Strahlentherapie und Onkologie 2026 Open access

Read full text
Authors: Sören Schnellhardt, Simon Böke, Silke Tribius, Mechthild Krause, Marlen Haderlein, Alexander Rühle, Christoph Süß, Annett Linge, Markus Hecht, Panagiotis Balermpas, Head and Neck Cancer Expert Panel of the German Society of Radiation Oncology DEGRO
DOI: 10.1007/s00066-026-02511-6
Cited by: 2
References: 13

Abstract

first randomized phase III trials demonstrating a prognostic benefit of perioperative or adjuvant immune checkpoint inhibition (ICI) in the curative treatment of resectable locally

Fields of Study & Subjects

Head and Neck Cancer Studies Esophageal Cancer Research and Treatment Radiopharmaceutical Chemistry and Applications

Publication details

Journal / source
Strahlentherapie und Onkologie
Publisher
Springer Science and Business Media LLC
Volume
202
Issue
4
Pages
359–361
Publication date
17 February 2026
Language
EN